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Toward a Better Understanding of...




The metabotropic glutamate receptor, mGluR5, is a G protein-coupled receptor (GPCR) 
widely expressed in the brain where it is linked to various developmental pathways 
involved in intellectual disabilities such as autism spectrum disorders. Most GPCRs are 
located on the surface of the cell where they receive signals from the environment which 
they convert into signals inside the cell. What makes mGluR5 unique is that most of 
it is inside the cell where it can also be activated and hence trigger signaling from its 
position inside the cell. Because cell surface mGluR5 activates different responses than 
the intracellular receptor, we hypothesized that compounds that inhibit mGluR5 might 
do so in a differential fashion. Specifically that some mGluR5 inhibitors might only 
block the cell surface receptor whereas others might block intracellular mGluR5. To test 
this hypothesis, I used primary cultures of spinal cord dorsal horn neurons which we 
have previously shown to express high levels of this receptor. When activated mGluR5 
leads to increased intracellular calcium which can be conveniently measured in dishes of 
cells using fluorescent calcium-sensitive dyes. By measuring a range of concentrations 
of 5 different inhibitors, I was able to deduce that certain drugs were more effective at 
inhibiting the cell surface vs. the intracellular receptor. This information will be useful 
in developing new therapies for disorders linked to mGluR5 signaling such as autism 
spectrum disorder.
